Candel Therapeutics, Inc. (CADL)
USD 6.53
(-1.06%)
USD 6.53
(-1.06%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | 125 Thousand | 125 Thousand | 125 Thousand | 125 Thousand |
| Cost of Revenue | 23.98 Million | 987 Thousand | 232 Thousand | - | 6.6 Million |
| Gross Profit | -23.98 Million | -862 Thousand | -107 Thousand | 125 Thousand | -6.48 Million |
| Operating Expenses | 14.41 Million | 34.79 Million | 24.77 Million | 13.31 Million | 8.59 Million |
| Selling, General and Administrative Expenses | 14.41 Million | 14.06 Million | 10.67 Million | 5.18 Million | 2.55 Million |
| Research and Development Expenses | 24.5 Million | 20.78 Million | 15.17 Million | 8.75 Million | 6.6 Million |
| Other Expenses | -24.5 Million | -48 Thousand | -1.07 Million | -624 Thousand | -571 Thousand |
| Cost and Expenses | 38.39 Million | 34.79 Million | 24.77 Million | 13.31 Million | 8.59 Million |
| Operating Income | -38.39 Million | -34.72 Million | -25.72 Million | -13.81 Million | -9.03 Million |
| Interest Expense | 514 Thousand | 490 Thousand | 53 Thousand | - | - |
| Income Tax Expense | - | -15.92 Million | 53 Thousand | 4.49 Million | -226 Thousand |
| Earnings before Tax | -37.93 Million | -18.79 Million | -36.12 Million | -17.68 Million | -8.24 Million |
| Net Income | -37.93 Million | -2.86 Million | -36.17 Million | -22.17 Million | -8.01 Million |
| Earnings Per Share Basic | -1.31 | -0.10 | -1.26 | -0.76 | -0.27 |
| Earnings Per Share Diluted | -1.31 | -0.10 | -1.26 | -0.76 | -0.27 |
| Weighted Average Shares Outstanding | 28.93 Million | 28.82 Million | 28.68 Million | 29.14 Million | 29.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 28.93 Million | 28.82 Million | 28.68 Million | 29.14 Million | 29.14 Million |
| Gross Margin | - | -6.90 | -0.86 | 1.00 | -51.86 |
| EBIT Margin | - | -408.35 | -195.34 | -67.92 | -60.63 |
| Profit Margin | - | -22.93 | -289.42 | -177.39 | -64.11 |
| EBITDA | -37.43 Million | -17.31 Million | -25.49 Million | -13.71 Million | -8.19 Million |
| Earnings Before Tax Margin | - | -277.78 | -205.81 | -110.48 | -72.30 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 1.77 Million | - | - | - |
| Cost of Revenue | 249 Thousand | 251 Thousand | 312 Thousand | 1.2 Million | 306 Thousand | 295 Thousand |
| Gross Profit | -249 Thousand | -251 Thousand | 1.46 Million | -1.2 Million | -306 Thousand | -295 Thousand |
| Operating Expenses | 8.32 Million | 7.65 Million | 10 Million | 37.19 Million | 8.86 Million | 9.56 Million |
| Selling, General and Administrative Expenses | 3.59 Million | 3.8 Million | 3.06 Million | - | 3.01 Million | 3.64 Million |
| Research and Development Expenses | 4.73 Million | 3.85 Million | 6.94 Million | - | 5.84 Million | 5.93 Million |
| Other Expenses | -4.97 Million | - | 12 Thousand | - | - | - |
| Cost and Expenses | 8.57 Million | 7.9 Million | 10.31 Million | 38.39 Million | 8.86 Million | 9.56 Million |
| Operating Income | -8.57 Million | -7.9 Million | -10.31 Million | -38.39 Million | -8.86 Million | -9.57 Million |
| Interest Expense | 567 Thousand | 646 Thousand | 673 Thousand | -2.59 Million | -669 Thousand | 644 Thousand |
| Income Tax Expense | 1.00 | 207.72 Thousand | 386 Thousand | - | -90 Thousand | 644 Thousand |
| Earnings before Tax | -22.23 Million | -8.22 Million | -11.09 Million | -37.93 Million | -8.43 Million | -9.61 Million |
| Net Income | -22.23 Million | -8.22 Million | -11.09 Million | -37.93 Million | -8.43 Million | -9.61 Million |
| Earnings Per Share Basic | -0.74 | -0.28 | -0.38 | - | -0.29 | -0.33 |
| Earnings Per Share Diluted | -0.74 | -0.28 | -0.38 | - | -0.29 | -0.33 |
| Weighted Average Shares Outstanding | 29.87 Million | 29.19 Million | 28.98 Million | 28.93 Million | 28.91 Million | 28.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 29.87 Million | 29.19 Million | 28.98 Million | 28.93 Million | 28.91 Million | 28.91 Million |
| Gross Margin | - | - | 0.82 | - | - | - |
| EBIT Margin | - | - | -5.63 | - | - | - |
| Profit Margin | - | - | -6.25 | - | - | - |
| EBITDA | -8.32 Million | -7.65 Million | -10 Million | - | -8.86 Million | -8.87 Million |
| Earnings Before Tax Margin | - | - | -5.81 | - | - | - |
300898
CULT
3321
FLOWS
CCCS
OLPX